Please use this identifier to cite or link to this item: http://nopr.niscair.res.in/handle/123456789/18999
Full metadata record
DC FieldValueLanguage
dc.contributor.authorSharma, B K-
dc.contributor.authorRay, A-
dc.contributor.authorKaur, S-
dc.contributor.authorGupta, Sanjay-
dc.date.accessioned2013-06-13T05:11:44Z-
dc.date.available2013-06-13T05:11:44Z-
dc.date.issued1999-03-
dc.identifier.issn0975-1009 (Online); 0019-5189 (Print)-
dc.identifier.urihttp://hdl.handle.net/123456789/18999-
dc.description223-227en_US
dc.description.abstractCarcinoma of the breast has an unpredictable biological behaviour. Several oncogenes have been implicated in the progression of breast cancer. Immunohistochemical staining of c-erbB-2 (Neu) oncoprotein and mutant p53 protein on 45 cases of infiltrating duct carcinoma (IDC) of the breast revealed 33% membrane positivity of c-erbB-2 oncoprotein, 46% nuclear positivity of mutated p53 protein, 33% and 84% membrane positivity of EGF-R and EMA respectively. Staining profile of c-erb-B2 oncoprotein in various histological subtypes of IDC of the breast indicated a high positivity rate in comedo followed by NOS and cibriform subtype. Similarly, high incidence of immunopositivity of mutated p53 protein was observed in comedo and cibriform subtypes while papillary carcinoma were found exclusively positive for mutated p53 protein. Interestingly, tubular subtype of IDC was not positive for c-crbB-2 oncoprotein as well as p53 mutant protein . Further, comedo and cibri form subtypes of IDC revealed 'high grade' histological features of tumour of the breast with high mitotic count, presence of marked pleomorphism and multinucleation thus, reflecting a positive relationship with overexpression of c-erbB-2 (Neu) oncoprotein as well as mutant p53 protein . The results on immune expression of c-erbB-2 oncoprotein and mutated p53 protein in various histological subtypes of IDC of the breast demonstrated c-erbB-2 status as an important predictor and also indicated that oncogene product may be involved in growth factor response pathway.en_US
dc.language.isoen_USen_US
dc.publisherNISCAIR-CSIR, Indiaen_US
dc.rights CC Attribution-Noncommercial-No Derivative Works 2.5 Indiaen_US
dc.sourceIJEB Vol.37(03) [March 1999]en_US
dc.titleImmunohistochemical co-expression of c-erbb-2/Neu oncoprotein, altered tumour suppressor (p53) protein, EGF-R and EMA in histological subtypes of infiltrating duct carcinoma of the breasten_US
dc.typeArticleen_US
Appears in Collections:IJEB Vol.37(03) [March 1999]

Files in This Item:
File Description SizeFormat 
IJEB 37(3) 223-227.pdf1.28 MBAdobe PDFView/Open


Items in NOPR are protected by copyright, with all rights reserved, unless otherwise indicated.